The DOJ’s Whistleblower Program and Leniency
March 19, 2026, 6:36 PM
By: Daniel K. Oakes
The DOJ Antitrust Division's new Whistleblower Rewards Program could have negative unintended consequences for the leniency program and corporate compliance programs. I wrote about it in an article just published in Law360, titled “How Internal Reporting Could Benefit Antitrust Whistleblowing.”
The Whistleblower Rewards Program has caused a stir in the antitrust community and will certainly be the topic of much discussion at the ABA Antitrust Spring Meeting next week. It signifies a sea change in how the government approaches criminal antitrust case generation. Where the DOJ formerly relied on its long-running (and massively successful) corporate leniency program, it now looks to incentivize individual employees to race against the company to report directly to the government.
I recently spoke on a panel at GCR Live: Cartels where I raised some potential risks of the program that have not been widely discussed. Namely, because whistleblowers can receive such massive payments in exchange for their reports, they will be heavily incentivized to circumvent internal corporate reporting altogether.
This could damage the very corporate compliance systems that the DOJ has encouraged for years, and limit the ability of companies to detect, investigate, and address antitrust issues internally. This includes the ability to seek corporate leniency, which is often the best way for the DOJ to obtain the fulsome evidence needed to win antitrust conspiracy cases.
I propose that the program be altered to incentivize potential whistleblowers to make internal reports and cooperate with internal investigations first, perhaps by reserving the largest whistleblower rewards for those who do so, comply and assist with corporate investigations, and ultimately yield accompanying leniency applications. This is modeled in other federal whistle-blower programs, such as the CFTC and the SEC programs.
The DOJ would not need to close the door to direct government reporting first, preserving the leniency-like race it wants to engender. But altering incentives could increase the chances that the Whistleblower Rewards Program does not ultimately cannibalize the Leniency Program.
If the whistleblower program inadvertently discourages internal reporting or undermines incentives for companies to seek leniency, it could reduce the government's ability to bring strong criminal cartel cases.

To subscribe to our publications, click here.
News & Insights
News & Insights
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
Axinn Represents Modular in $4 Billion Acquisition by Qualcomm
Deals & Cases
Antitrust
Will New DOJ Timing Agreement Deliver Faster Merger Clearances?
Axinn Viewpoints
Antitrust
Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
Byline Articles
Antitrust
Women Leaders in Life Sciences Law
Speaking Engagement
Litigation & Trials
American Bar Association: Inside Antitrust Enforcement—Former Government Perspectives
Webinar
Antitrust
What's the Skinny on SCOTUS' Skinny Label Decision?
Webinar
Intellectual Property
National Bar Association Corporate Counsel Leadership Summit
Speaking Engagement
Antitrust
FTC Prescribes Lower Out-of-Pocket Insulin Costs in Settlement with Caremark
Axinn Viewpoints
Antitrust
The FTC’s Record $12 Million HSR Penalty: Deal Structuring, Avoidance, and the Line Between Them
Axinn Viewpoints
Antitrust
